Literature DB >> 16122475

Deregulated p21(WAF1) overexpression impacts survival of surgically resected esophageal squamous cell carcinoma patients.

Yih-Gang Goan1, Hon-Ki Hsu, Huang-Chou Chang, Yi-Ping Chou, Ke-Hsin Chiang, Jiin-Tsuey Cheng.   

Abstract

BACKGROUND: Prognostic effects of cell cycle regulation associated tumor suppressor genes for esophageal squamous cell carcinoma patients are controversial. Clarifying the effects of these genes is beneficial for optimizing patient's outcome.
METHODS: Forty esophageal squamous cell carcinoma patients were included in the study. Tissue samples were analyzed for cell proliferation, DNA content, mutation of p53 gene, and expression of p21 and p53 proteins. Prognostic effects of these parameters were assessed by multivariate analysis.
RESULTS: Seventy-five percent of tumors exhibited aneuploid DNA content. Significantly higher S-phase fractions were detected in tumor samples (p < 0.001). The p53 gene mutated in 52.5% (21 of 40) of tumor samples, p53 immunostaining was detected in 62.5% (25 of 40) of tumor tissues and 50% of tumors over expressed p21. Overexpression of p21 protein did not correlate with p53 gene status, but significantly correlated with abnormal DNA content (p = 0.028). Advanced pTNM stage, lymph node metastasis and p21 overexpression conferred survival disadvantages in univariate analysis (p = 0.013, 0.045 and 0.017, respectively). A Cox multivariable analysis revealed pTNM stage (IIB/III/IV vs. I/IIA; p = 0.024) associated with p21 overexpression (positive vs. negative; p = 0.035) as independent prognostic factors in esophageal squamous cell carcinomas. Surprisingly, p21 overexpression significantly compromised the survival of patients with mutated p53 gene (p = 0.035). However, no significant dismal effect of p21 overexpression can be seen in patients with wild-type p53 gene (p = 0.175).
CONCLUSIONS: Overexpression of p21 correlates with chromosomal instability and serves as an adverse prognostic predictor for patients with esophageal squamous cell carcinoma. Its adverse effect is more prominent when the p53 gene is mutated.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16122475     DOI: 10.1016/j.athoracsur.2005.03.050

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  9 in total

1.  Association of p53/p21 expression with cigarette smoking and prognosis in esophageal squamous cell carcinoma patients.

Authors:  Noushin Taghavi; Firouzeh Biramijamal; Masoud Sotoudeh; Omeed Moaven; Hooman Khademi; Mohammad Reza Abbaszadegan; Reza Malekzadeh
Journal:  World J Gastroenterol       Date:  2010-10-21       Impact factor: 5.742

2.  Zinc replenishment reverses overexpression of the proinflammatory mediator S100A8 and esophageal preneoplasia in the rat.

Authors:  Cristian Taccioli; Shao-Gui Wan; Chang-Gong Liu; Hansjuerg Alder; Stefano Volinia; John L Farber; Carlo M Croce; Louise Y Y Fong
Journal:  Gastroenterology       Date:  2008-11-24       Impact factor: 22.682

Review 3.  Systematic review and meta-analysis of tumor biomarkers in predicting prognosis in esophageal cancer.

Authors:  Meilan Chen; Jizheng Huang; Zhenli Zhu; Jun Zhang; Ke Li
Journal:  BMC Cancer       Date:  2013-11-11       Impact factor: 4.430

4.  CGK733-induced LC3 II formation is positively associated with the expression of cyclin-dependent kinase inhibitor p21Waf1/Cip1 through modulation of the AMPK and PERK/CHOP signaling pathways.

Authors:  Yufeng Wang; Yasuhiro Kuramitsu; Byron Baron; Takao Kitagawa; Kazuhiro Tokuda; Junko Akada; Kazuyuki Nakamura
Journal:  Oncotarget       Date:  2015-11-24

5.  Polymorphism rs2395655 affects LEDGF/p75 binding activity and p21WAF1/CIP1 gene expression in esophageal squamous cell carcinoma.

Authors:  Rong Guo; Yunan Ma; Min Zhao; Wenlong Zhang; Guo An; Baojun Chen; Yiping Song; Hui Xu; Yong Li
Journal:  Cancer Med       Date:  2019-03-10       Impact factor: 4.452

6.  Clinical and Prognostic Implications of P21 (WAF1/CIP1) Expression in Patients with Esophageal Cancer: A Systematic Review and Meta-Analysis.

Authors:  Junbo Wu; Liang Liu; Feng Wu; Li Qiu; Ming Luo; Qing Ke; Xinzhou Deng; Zhiguo Luo
Journal:  Dis Markers       Date:  2020-01-07       Impact factor: 3.434

Review 7.  Cyclin-dependent kinase inhibitors in malignant hematopoiesis.

Authors:  Alessia Schirripa; Veronika Sexl; Karoline Kollmann
Journal:  Front Oncol       Date:  2022-08-11       Impact factor: 5.738

Review 8.  A systematic review and meta-analysis of somatic and germline DNA sequence biomarkers of esophageal cancer survival, therapy response and stage.

Authors:  J M Findlay; M R Middleton; I Tomlinson
Journal:  Ann Oncol       Date:  2014-09-11       Impact factor: 32.976

9.  Prognostic value of an immunohistochemical signature in patients with esophageal squamous cell carcinoma undergoing radical esophagectomy.

Authors:  Jin Meng; Junhua Zhang; Yingjie Xiu; Yan Jin; Jiaqing Xiang; Yongzhan Nie; Shen Fu; Kuaile Zhao
Journal:  Mol Oncol       Date:  2018-01-06       Impact factor: 6.603

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.